Associated Papers
Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
Van Hout CV et al.
Nature, 2020
33087929 (PubMed )
Supplement: 41586_2020_2853_MOESM11_ESM.xlsx › Sheet1
Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.
Hirotsu Y et al.
International Journal of Molecular Sciences, 2020
32486089 (PubMed )
Supplement: ijms-21-03895-s001.zip › Supplemental_Table_2.xlsx › ENIGMA
Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies.
Rizzolo P et al.
Breast Cancer Research and Treatment, 2017
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O et al.
Breast Cancer Research and Treatment, 2017
Select a paper to view details